Skip to main content
OpenTrials

Clinical trial condition

Leukemia, Myeloid

Explore clinical trials studying Leukemia, Myeloid. Study availability and eligibility vary by location and protocol.

3,104 public trials 618 recruiting studies
Refine in advanced search Browse all conditions

Leukemia, Myeloid trial results

Completed

A Study of Clofarabine for Older Patients With Newly Diagnosed Acute Myelogenous Leukemia (AML) (CLASSIC II)

NCT00373529

Conditions
Acute Myelogenous Leukemia, Acute Myeloid Leukemia, Hematologic Diseases, +6 more
Locations
  • Mayo Clinical Hospital Phoenix, Arizona, United States
  • Arizona Cancer Center Tucson, Arizona, United States
  • USC/Norris Comprehensive Cancer Center and Hospital Los Angeles, California, United States
  • Scripps Cancer Center San Diego, California, United States
View all 20 locations
View Trial Details
Completed

A Study of Clofarabine in Combination With Etoposide and Cyclophosphamide in Children With Acute Leukemias.

NCT00315705

Conditions
Acute Lymphoblastic Leukemia, Acute Myelogenous Leukemia, Hematologic Diseases, +13 more
Locations
  • Children's Hospital of Alabama Birmingham, Alabama, United States
  • Children's Hospital of Los Angeles Los Angeles, California, United States
  • Rady Children's Hospital San Diego, California, United States
  • Connecticut Children's Medical Center Hartford, Connecticut, United States
View all 13 locations
View Trial Details
Completed

A Study of Clofarabine and Cytarabine for Older Patients With Relapsed or Refractory Acute Myelogenous Leukemia (AML)(CLASSIC I)

NCT00317642

Conditions
Acute Myelogenous Leukemia, Hematologic Diseases, Hemic and Lymphatic Diseases, +5 more
Locations
  • Mayo Clinical Hospital Scottsdale, Arizona, United States
  • Arizona Cancer Center Tucson, Arizona, United States
  • University of Arkansas for Medical Sciences, Arkansas Cancer Research Center Little Rock, Arkansas, United States
  • Scripps Cancer Center La Jolla, California, United States
View all 57 locations
View Trial Details
Completed

Adding Lomustine to Chemotherapy in Older Patients With Acute Myelogenous Leukemia (AML), and Allogeneic Transplantation for Patients From 60 to 65 Years Old

NCT00590837

Conditions
Acute Myeloid Leukemia, Hematologic Diseases, Hemic and Lymphatic Diseases, +5 more
Locations
  • Services maladies du sang, cancérologie, Hôpital Sud, CHU Amiens Amiens, France
  • Service des maladies du sang, Centre Hospitalier Universitaire d'Angers Angers, France
  • Service Hématologie, Centre Hospitalier Annecy Annecy, France
  • C.H Victor Dupouy Argenteuil, France
View all 32 locations
View Trial Details
Completed

Open-label Study to Evaluate the Safety, PK, and PD of MEK Inhibitor GSK1120212 in Subjects With Relapsed or Refractory Leukemias

NCT00920140

Conditions
Cancer, Hematologic Diseases, Hematologic Neoplasms, +7 more
Locations
  • GSK Investigational Site Birmingham, Alabama, United States
  • GSK Investigational Site Duarte, California, United States
  • GSK Investigational Site Los Angeles, California, United States
  • GSK Investigational Site San Francisco, California, United States
View all 28 locations
View Trial Details

Related conditions